Carcinoma, Bronchogenic  >>  Xegafri (rociletinib)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xegafri (rociletinib) / Clovis
NCT02547675: Rociletinib (CO-1686) USA Expanded Access Program

No Longer Available
N/A
US
Rociletinib, CO-1686
Clovis Oncology, Inc.
Non-small Cell Lung Cancer
 
 

Download Options